Global Artificial Heart Implant Market Research Report 2022

Due to the COVID-19 pandemic, the global Artificial Heart Implant market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, the Europe Artificial Heart Implant market is estimated at US$ million in 2022, while the United States and China are forecast to reach US$ million and US$ million by 2028, respectively. The proportion of the United States is % in 2022, while Chinese percentage is %, and it is predicted that China market share will reach % in 2028, trailing a CAGR of % through the analysis period. As for the Europe Artificial Heart Implant landscape, Germany is projected to reach US$ million by 2028. and in Asia, the notable markets are Japan and South Korea, CAGR is % and % respectively for the next 6-year period.

Ventricular Assist Devices accounting for % of the Artificial Heart Implant global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Acute Myocardial Infarction segment is altered to an % CAGR throughout this forecast period and will hold a share about % in 2028.

The global major manufacturers of Artificial Heart Implant include Medtronic, Boston Scientific, Abbott, Terumo, B.Braun, SynCardia, BiVACOR, CARMAT and ReinHeart TAH GmbH, etc. In terms of revenue, the global 3 largest players have a % market share of Artificial Heart Implant in 2021.

This report focuses on Artificial Heart Implant volume and value at the global level, regional level, and company level. From a global perspective, this report represents overall Artificial Heart Implant market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan, etc.

Global Artificial Heart Implant Market: Segment Analysis

The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth.


Segment by Type


Ventricular Assist Devices

Total Artificial Hearts


Segment by Application


Acute Myocardial Infarction

Unstable Angina

Angina Pectoris

By Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Russia

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Indonesia

Thailand

Malaysia

Latin America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE


By Company


Medtronic

Boston Scientific

Abbott

Terumo

B.Braun

SynCardia

BiVACOR

CARMAT

ReinHeart TAH GmbH

Cleveland Heart

AbioMed

OregonHeart, Inc.

Berlin Heart

Jarvik Heart Inc.

Sun Medical Technology Research

ReliantHeart